Crosstalk between Oxidative Stress and Inflammation Induced by Ionizing Radiation in Healthy and Cancerous Cells

Hulvat, M.C. Cancer incidence and trends. Surg. Clin. North Am., 2020, 100(3), 469-481.
[http://dx.doi.org/10.1016/j.suc.2020.01.002] [PMID: 32402294]

Yahya, E.B.; Alqadhi, A.M. Recent trends in cancer therapy: A review on the current state of gene delivery. Life Sci., 2021, 269, 119087.
[http://dx.doi.org/10.1016/j.lfs.2021.119087] [PMID: 33476633]

Bidram, E.; Esmaeili, Y.; Ranji-Burachaloo, H.; Al-Zaubai, N.; Zarrabi, A.; Stewart, A.; Dunstan, D.E. A concise review on cancer treatment methods and delivery systems. J. Drug Deliv. Sci. Technol., 2019, 54, 101350.
[http://dx.doi.org/10.1016/j.jddst.2019.101350]

Ural, K.; Isa, C. Toxicology; Elsevier, 2021, pp. 233-241.

Nuszkiewicz, J.; Woźniak, A.; Szewczyk-Golec, K. Ionizing radiation as a source of oxidative stress-the protective role of melatonin and vitamin D. Int. J. Mol. Sci., 2020, 21(16), 5804.
[http://dx.doi.org/10.3390/ijms21165804] [PMID: 32823530]

Formenti, S.C.; Demaria, S. Combining radiotherapy and cancer immunotherapy: A paradigm shift. J. Natl. Cancer Inst., 2013, 105(4), 256-265.
[http://dx.doi.org/10.1093/jnci/djs629] [PMID: 23291374]

Khansari, N.; Shakiba, Y.; Mahmoudi, M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat. Inflamm. Allergy Drug Discov., 2009, 3(1), 73-80.
[http://dx.doi.org/10.2174/187221309787158371] [PMID: 19149749]

Krylatov, A.V.; Maslov, L.N.; Voronkov, N.S.; Boshchenko, A.A.; Popov, S.V.; Gomez, L.; Wang, H.; Jaggi, A.S.; Downey, J.M. Reactive oxygen species as intracellular signaling molecules in the cardiovascular system. Curr. Cardiol. Rev., 2018, 14(4), 290-300.
[http://dx.doi.org/10.2174/1573403X14666180702152436] [PMID: 29962348]

Liu, R.; Bian, Y.; Liu, L.; Liu, L.; Liu, X.; Ma, S. Molecular pathways associated with oxidative stress and their potential applications in radiotherapy (Review). Int. J. Mol. Med., 2022, 49(5), 65.
[http://dx.doi.org/10.3892/ijmm.2022.5121] [PMID: 35293589]

Raviraj, J.; Bokkasam, V.; Kumar, V.; Reddy, U.; Suman, V. Radiosensitizers, radioprotectors, and radiation mitigators. Indian J. Dent. Res., 2014, 25(1), 83-90.
[http://dx.doi.org/10.4103/0970-9290.131142] [PMID: 24748306]

Mun, G.I.; Kim, S.; Choi, E.; Kim, C.S.; Lee, Y.S. Pharmacology of natural radioprotectors. Arch. Pharm. Res., 2018, 41(11), 1033-1050.
[http://dx.doi.org/10.1007/s12272-018-1083-6] [PMID: 30361949]

Laube, M.; Kniess, T.; Pietzsch, J. Development of antioxidant COX-2 inhibitors as radioprotective agents for radiation therapy-a hypothesis-driven review. Antioxidants, 2016, 5(2), 14.
[http://dx.doi.org/10.3390/antiox5020014] [PMID: 27104573]

Hall, E.J.; Giaccia, A.J. Radiobiology for the radiologist. Springer, 2018.

Shimizu, S.; Konishi, A.; Nishida, Y.; Mizuta, T.; Nishina, H.; Yamamoto, A.; Tsujimoto, Y. Involvement of JNK in the regulation of autophagic cell death. Oncogene, 2010, 29(14), 2070-2082.
[http://dx.doi.org/10.1038/onc.2009.487] [PMID: 20101227]

Duprez, L.; Wirawan, E.; Berghe, T.V.; Vandenabeele, P. Major cell death pathways at a glance. Microbes Infect., 2009, 11(13), 1050-1062.
[http://dx.doi.org/10.1016/j.micinf.2009.08.013] [PMID: 19733681]

Yu, X.; He, S. The interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathways. Virol. J., 2016, 13(1), 77.
[http://dx.doi.org/10.1186/s12985-016-0528-0] [PMID: 27154074]

Galluzzi, L.; Vitale, I.; Aaronson, S.A.; Abrams, J.M.; Adam, D.; Agostinis, P.; Alnemri, E.S.; Altucci, L.; Amelio, I.; Andrews, D.W.; Annicchiarico-Petruzzelli, M.; Antonov, A.V.; Arama, E.; Baehrecke, E.H.; Barlev, N.A.; Bazan, N.G.; Bernassola, F.; Bertrand, M.J.M.; Bianchi, K.; Blagosklonny, M.V.; Blomgren, K.; Borner, C.; Boya, P.; Brenner, C.; Campanella, M.; Candi, E.; Carmona-Gutierrez, D.; Cecconi, F.; Chan, F.K.M.; Chandel, N.S.; Cheng, E.H.; Chipuk, J.E.; Cidlowski, J.A.; Ciechanover, A.; Cohen, G.M.; Conrad, M.; Cubillos-Ruiz, J.R.; Czabotar, P.E.; D’Angiolella, V.; Dawson, T.M.; Dawson, V.L.; De Laurenzi, V.; De Maria, R.; Debatin, K.M.; DeBerardinis, R.J.; Deshmukh, M.; Di Daniele, N.; Di Virgilio, F.; Dixit, V.M.; Dixon, S.J.; Duckett, C.S.; Dynlacht, B.D.; El-Deiry, W.S.; Elrod, J.W.; Fimia, G.M.; Fulda, S.; García-Sáez, A.J.; Garg, A.D.; Garrido, C.; Gavathiotis, E.; Golstein, P.; Gottlieb, E.; Green, D.R.; Greene, L.A.; Gronemeyer, H.; Gross, A.; Hajnoczky, G.; Hardwick, J.M.; Harris, I.S.; Hengartner, M.O.; Hetz, C.; Ichijo, H.; Jäättelä, M.; Joseph, B.; Jost, P.J.; Juin, P.P.; Kaiser, W.J.; Karin, M.; Kaufmann, T.; Kepp, O.; Kimchi, A.; Kitsis, R.N.; Klionsky, D.J.; Knight, R.A.; Kumar, S.; Lee, S.W.; Lemasters, J.J.; Levine, B.; Linkermann, A.; Lipton, S.A.; Lockshin, R.A.; López-Otín, C.; Lowe, S.W.; Luedde, T.; Lugli, E.; MacFarlane, M.; Madeo, F.; Malewicz, M.; Malorni, W.; Manic, G.; Marine, J.C.; Martin, S.J.; Martinou, J.C.; Medema, J.P.; Mehlen, P.; Meier, P.; Melino, S.; Miao, E.A.; Molkentin, J.D.; Moll, U.M.; Muñoz-Pinedo, C.; Nagata, S.; Nuñez, G.; Oberst, A.; Oren, M.; Overholtzer, M.; Pagano, M.; Panaretakis, T.; Pasparakis, M.; Penninger, J.M.; Pereira, D.M.; Pervaiz, S.; Peter, M.E.; Piacentini, M.; Pinton, P.; Prehn, J.H.M.; Puthalakath, H.; Rabinovich, G.A.; Rehm, M.; Rizzuto, R.; Rodrigues, C.M.P.; Rubinsztein, D.C.; Rudel, T.; Ryan, K.M.; Sayan, E.; Scorrano, L.; Shao, F.; Shi, Y.; Silke, J.; Simon, H.U.; Sistigu, A.; Stockwell, B.R.; Strasser, A.; Szabadkai, G.; Tait, S.W.G.; Tang, D.; Tavernarakis, N.; Thorburn, A.; Tsujimoto, Y.; Turk, B.; Vanden Berghe, T.; Vandenabeele, P.; Vander Heiden, M.G.; Villunger, A.; Virgin, H.W.; Vousden, K.H.; Vucic, D.; Wagner, E.F.; Walczak, H.; Wallach, D.; Wang, Y.; Wells, J.A.; Wood, W.; Yuan, J.; Zakeri, Z.; Zhivotovsky, B.; Zitvogel, L.; Melino, G.; Kroemer, G. Molecular mechanisms of cell death: recommendations of the Nomenclature committee on cell death 2018. Cell Death Differ., 2018, 25(3), 486-541.
[http://dx.doi.org/10.1038/s41418-017-0012-4] [PMID: 29362479]

Kroemer, G.; Galluzzi, L.; Vandenabeele, P.; Abrams, J.; Alnemri, E.S.; Baehrecke, E.H.; Blagosklonny, M.V.; El-Deiry, W.S.; Golstein, P.; Green, D.R.; Hengartner, M.; Knight, R.A.; Kumar, S.; Lipton, S.A.; Malorni, W.; Nuñez, G.; Peter, M.E.; Tschopp, J.; Yuan, J.; Piacentini, M.; Zhivotovsky, B.; Melino, G. Classification of cell death: Recommendations of the nomenclature committee on cell death 2009. Cell Death Differ., 2009, 16(1), 3-11.
[http://dx.doi.org/10.1038/cdd.2008.150] [PMID: 18846107]

van Doorn, W.G. Classes of programmed cell death in plants, compared to those in animals. J. Exp. Bot., 2011, 62(14), 4749-4761.
[http://dx.doi.org/10.1093/jxb/err196] [PMID: 21778180]

Mizushima, N.; Komatsu, M. Autophagy: Renovation of cells and tissues. Cell, 2011, 147(4), 728-741.
[http://dx.doi.org/10.1016/j.cell.2011.10.026] [PMID: 22078875]

Glick, D.; Barth, S.; Macleod, K.F. Autophagy: Cellular and molecular mechanisms. J. Pathol., 2010, 221(1), 3-12.
[http://dx.doi.org/10.1002/path.2697] [PMID: 20225336]

Bozhkov, P.V. Plant autophagy: Mechanisms and functions. J. Exp. Bot., 2018, 69(6), 1281-1285.
[http://dx.doi.org/10.1093/jxb/ery070] [PMID: 29547996]

Pollack, J.; Harris, S.; Marten, M. Autophagy in filamentous fungi. Fungal Genet. Biol., 2009, 46(1), 1-8.
[http://dx.doi.org/10.1016/j.fgb.2008.10.010] [PMID: 19010432]

Galluzzi, L.; Vitale, I.; Abrams, J.M.; Alnemri, E.S.; Baehrecke, E.H.; Blagosklonny, M.V.; Dawson, T.M.; Dawson, V.L.; El-Deiry, W.S.; Fulda, S.; Gottlieb, E.; Green, D.R.; Hengartner, M.O.; Kepp, O.; Knight, R.A.; Kumar, S.; Lipton, S.A.; Lu, X.; Madeo, F.; Malorni, W.; Mehlen, P.; Nuñez, G.; Peter, M.E.; Piacentini, M.; Rubinsztein, D.C.; Shi, Y.; Simon, H-U.; Vandenabeele, P.; White, E.; Yuan, J.; Zhivotovsky, B.; Melino, G.; Kroemer, G. Molecular definitions of cell death subroutines: Recommendations of the nomenclature committee on cell death 2012. Cell Death Differ., 2012, 19(1), 107-120.
[http://dx.doi.org/10.1038/cdd.2011.96] [PMID: 21760595]

Proskuryakov, S.Y.; Konoplyannikov, A.G.; Gabai, V.L. Necrosis: A specific form of programmed cell death? Exp. Cell Res., 2003, 283(1), 1-16.
[http://dx.doi.org/10.1016/S0014-4827(02)00027-7] [PMID: 12565815]

Khalid, N.; Azimpouran, M. Necrosis. Treasure Island (FL). StatPearls Publishing, 2023.

Galluzzi, L.; Maiuri, M.C.; Vitale, I.; Zischka, H.; Castedo, M.; Zitvogel, L.; Kroemer, G. Cell death modalities: Classification and pathophysiological implications. Cell Death Differ., 2007, 14(7), 1237-1243.
[http://dx.doi.org/10.1038/sj.cdd.4402148] [PMID: 17431418]

Sia, J.; Szmyd, R.; Hau, E.; Gee, H.E. Molecular mechanisms of radiation-induced cancer cell death: A primer. Front. Cell Dev. Biol., 2020, 8, 41.
[http://dx.doi.org/10.3389/fcell.2020.00041] [PMID: 32117972]

Baskar, R.; Lee, K.A.; Yeo, R.; Yeoh, K.W. Cancer and radiation therapy: Current advances and future directions. Int. J. Med. Sci., 2012, 9(3), 193-199.
[http://dx.doi.org/10.7150/ijms.3635] [PMID: 22408567]

Kim, B.; Hong, Y.; Lee, S.; Liu, P.; Lim, J.; Lee, Y.; Lee, T.; Chang, K.; Hong, Y. Therapeutic implications for overcoming radiation resistance in cancer therapy. Int. J. Mol. Sci., 2015, 16(11), 26880-26913.
[http://dx.doi.org/10.3390/ijms161125991] [PMID: 26569225]

Kim, W.; Lee, S.; Seo, D.; Kim, D.; Kim, K.; Kim, E.; Kang, J.; Seong, K.M.; Youn, H.; Youn, B. Cellular stress responses in radiotherapy. Cells, 2019, 8(9), 1105.
[http://dx.doi.org/10.3390/cells8091105] [PMID: 31540530]

Vaes, R.D.W.; Hendriks, L.E.L.; Vooijs, M.; De Ruysscher, D. Biomarkers of radiotherapy-induced immunogenic cell death. Cells, 2021, 10(4), 930.
[http://dx.doi.org/10.3390/cells10040930] [PMID: 33920544]

Maier, P.; Hartmann, L.; Wenz, F.; Herskind, C. Cellular pathways in response to ionizing radiation and their targetability for tumor radiosensitization. Int. J. Mol. Sci., 2016, 17(1), 102.
[http://dx.doi.org/10.3390/ijms17010102] [PMID: 26784176]

Corre, I.; Guillonneau, M.; Paris, F. Membrane signaling induced by high doses of ionizing radiation in the endothelial compartment. Relevance in radiation toxicity. Int. J. Mol. Sci., 2013, 14(11), 22678-22696.
[http://dx.doi.org/10.3390/ijms141122678] [PMID: 24252908]

Chaurasia, M.; Bhatt, A.N.; Das, A.; Dwarakanath, B.S.; Sharma, K. Radiation-induced autophagy: Mechanisms and consequences. Free Radic. Res., 2016, 50(3), 273-290.
[http://dx.doi.org/10.3109/10715762.2015.1129534] [PMID: 26764568]

Desai, R. Cell death. Available from: https://drrajivdesaimd.com/2014/01/01/cell-death/

Manning, G.; Tichý, A.; Sirák, I.; Badie, C. Radiotherapy-associated long-term modification of expression of the inflammatory biomarker genes ARG1, BCL2L1, and MYC. Front. Immunol., 2017, 8, 412.
[http://dx.doi.org/10.3389/fimmu.2017.00412] [PMID: 28443095]

Gong, Y.; Fan, Z.; Luo, G.; Yang, C.; Huang, Q.; Fan, K.; Cheng, H.; Jin, K.; Ni, Q.; Yu, X.; Liu, C. The role of necroptosis in cancer biology and therapy. Mol. Cancer, 2019, 18(1), 100.
[http://dx.doi.org/10.1186/s12943-019-1029-8] [PMID: 31122251]

Eriksson, D.; Stigbrand, T. Radiation-induced cell death mechanisms. Tumour Biol., 2010, 31(4), 363-372.
[http://dx.doi.org/10.1007/s13277-010-0042-8] [PMID: 20490962]

Vitale, I.; Galluzzi, L.; Castedo, M.; Kroemer, G. Mitotic catastrophe: A mechanism for avoiding genomic instability. Nat. Rev. Mol. Cell Biol., 2011, 12(6), 385-392.
[http://dx.doi.org/10.1038/nrm3115] [PMID: 21527953]

Vakifahmetoglu, H.; Olsson, M.; Zhivotovsky, B. Death through a tragedy: Mitotic catastrophe. Cell Death Differ., 2008, 15(7), 1153-1162.
[http://dx.doi.org/10.1038/cdd.2008.47] [PMID: 18404154]

He, X.; Yang, A.; McDonald, D.G.; Riemer, E.C.; Vanek, K.N.; Schulte, B.A.; Wang, G.Y. MiR-34a modulates ionizing radiation-induced senescence in lung cancer cells. Oncotarget, 2017, 8(41), 69797-69807.
[http://dx.doi.org/10.18632/oncotarget.19267] [PMID: 29050242]

Campisi, J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol., 2013, 75(1), 685-705.
[http://dx.doi.org/10.1146/annurev-physiol-030212-183653] [PMID: 23140366]

Wang, G.; Cheng, X.; Zhang, J.; Liao, Y.; Jia, Y.; Qing, C. Possibility of inducing tumor cell senescence during therapy (Review). Oncol. Lett., 2021, 22(1), 496.
[http://dx.doi.org/10.3892/ol.2021.12757] [PMID: 33981358]

Kwon, S.; Ko, H.; You, D.G.; Kataoka, K.; Park, J.H. Nanomedicines for reactive oxygen species mediated approach: An emerging paradigm for cancer treatment. Acc. Chem. Res., 2019, 52(7), 1771-1782.
[http://dx.doi.org/10.1021/acs.accounts.9b00136] [PMID: 31241894]

del Río, L.A.; López-Huertas, E. ROS generation in peroxisomes and its role in cell signaling. Plant Cell Physiol., 2016, 57(7), pcw076.
[http://dx.doi.org/10.1093/pcp/pcw076] [PMID: 27081099]

Martínez, M.C.; Andriantsitohaina, R. Reactive nitrogen species: Molecular mechanisms and potential significance in health and disease. Antioxid. Redox Signal., 2009, 11(3), 669-702.
[http://dx.doi.org/10.1089/ars.2007.1993] [PMID: 19014277]

Doshi, S.B.; Khullar, K.; Sharma, R.K.; Agarwal, A. Role of reactive nitrogen species in male infertility. Reprod. Biol. Endocrinol., 2012, 10(1), 109.
[http://dx.doi.org/10.1186/1477-7827-10-109] [PMID: 23241221]

Bhattacharya, S. In Free radicals in human health and disease. Springer, 2015, 17-29.
[http://dx.doi.org/10.1007/978-81-322-2035-0_2]

Mittler, R. ROS are good. Trends Plant Sci., 2017, 22(1), 11-19.
[http://dx.doi.org/10.1016/j.tplants.2016.08.002] [PMID: 27666517]

Forrester, S.J.; Kikuchi, D.S.; Hernandes, M.S.; Xu, Q.; Griendling, K.K. Reactive oxygen species in metabolic and inflammatory signaling. Circ. Res., 2018, 122(6), 877-902.
[http://dx.doi.org/10.1161/CIRCRESAHA.117.311401] [PMID: 29700084]

Salim, S. Oxidative stress and psychological disorders. Curr. Neuropharmacol., 2014, 12(2), 140-147.
[http://dx.doi.org/10.2174/1570159X11666131120230309] [PMID: 24669208]

McKelvey, K.J.; Hudson, A.L.; Back, M.; Eade, T.; Diakos, C.I. Radiation, inflammation and the immune response in cancer. Mamm. Genome, 2018, 29(11-12), 843-865.
[http://dx.doi.org/10.1007/s00335-018-9777-0] [PMID: 30178305]

Wang, Y.; Qi, H.; Liu, Y.; Duan, C.; Liu, X.; Xia, T.; Chen, D.; Piao, H.; Liu, H.X. The double-edged roles of ROS in cancer prevention and therapy. Theranostics, 2021, 11(10), 4839-4857.
[http://dx.doi.org/10.7150/thno.56747] [PMID: 33754031]

Aggarwal, V.; Tuli, H.; Varol, A.; Thakral, F.; Yerer, M.; Sak, K.; Varol, M.; Jain, A.; Khan, M.; Sethi, G. Role of reactive oxygen species in cancer progression: Molecular mechanisms and recent advancements. Biomolecules, 2019, 9(11), 735.
[http://dx.doi.org/10.3390/biom9110735] [PMID: 31766246]

Yahyapour, R.; Amini, P.; Rezapour, S.; Cheki, M.; Rezaeyan, A.; Farhood, B.; Shabeeb, D.; Musa, A.E.; Fallah, H.; Najafi, M. Radiation-induced inflammation and autoimmune diseases. Mil. Med. Res., 2018, 5(1), 9.
[http://dx.doi.org/10.1186/s40779-018-0156-7] [PMID: 29554942]

Wei, J.; Wang, B.; Wang, H.; Meng, L.; Zhao, Q.; Li, X.; Xin, Y.; Jiang, X. Radiation-induced normal tissue damage: Oxidative stress and epigenetic mechanisms. Oxid Med Cell Longev, 2019, 2019, 3010342.
[http://dx.doi.org/10.1155/2019/3010342]

Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget, 2018, 9(6), 7204-7218.
[http://dx.doi.org/10.18632/oncotarget.23208] [PMID: 29467962]

Kato, J.; Svensson, C.I. Role of extracellular damage-associated molecular pattern molecules (DAMPs) as mediators of persistent pain. Prog. Mol. Biol. Transl. Sci., 2015, 131, 251-279.
[http://dx.doi.org/10.1016/bs.pmbts.2014.11.014] [PMID: 25744676]

Neher, M.D.; Weckbach, S.; Flierl, M.A.; Huber-Lang, M.S.; Stahel, P.F. Molecular mechanisms of inflammation and tissue injury after major trauma-is complement the “bad guy”? J. Biomed. Sci., 2011, 18(1), 90.
[http://dx.doi.org/10.1186/1423-0127-18-90] [PMID: 22129197]

Mavragani, I.V.; Laskaratou, D.A.; Frey, B.; Candéias, S.M.; Gaipl, U.S.; Lumniczky, K.; Georgakilas, A.G. Key mechanisms involved in ionizing radiation-induced systemic effects. A current review. Toxicol. Res., 2016, 5(1), 12-33.
[http://dx.doi.org/10.1039/c5tx00222b] [PMID: 30090323]

Ashley, N.T.; Weil, Z.M.; Nelson, R.J. Inflammation: Mechanisms, costs, and natural variation. Annu. Rev. Ecol. Evol. Syst., 2012, 43(1), 385-406.
[http://dx.doi.org/10.1146/annurev-ecolsys-040212-092530]

Kumar, H.; Kawai, T.; Akira, S. Pathogen recognition by the innate immune system. Int. Rev. Immunol., 2011, 30(1), 16-34.
[http://dx.doi.org/10.3109/08830185.2010.529976] [PMID: 21235323]

Gong, T.; Liu, L.; Jiang, W.; Zhou, R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol., 2020, 20(2), 95-112.
[http://dx.doi.org/10.1038/s41577-019-0215-7] [PMID: 31558839]

Kany, S.; Vollrath, J.T.; Relja, B. Cytokines in inflammatory disease. Int. J. Mol. Sci., 2019, 20(23), 6008.
[http://dx.doi.org/10.3390/ijms20236008] [PMID: 31795299]

Brooks, A.J.; Dehkhoda, F.; Kragelund, B.B. Cytokine receptors. Princ Endocrinol Horm Action, 2016.
[http://dx.doi.org/10.1007/978-3-319-27318-1_8-1]

Singh, V.; Gupta, D.; Arora, R. NF-κB as a key player in regulation of cellular radiation responses and identification of radiation countermeasures. Discoveries, 2015, 3(1), e35.
[http://dx.doi.org/10.15190/d.2015.27] [PMID: 32309561]

Lingappan, K. NF-κB in oxidative stress. Curr. Opin. Toxicol., 2018, 7, 81-86.
[http://dx.doi.org/10.1016/j.cotox.2017.11.002] [PMID: 29862377]

Barnabei, L.; Laplantine, E.; Mbongo, W.; Rieux-Laucat, F.; Weil, R. NF-κB: At the borders of autoimmunity and inflammation. Front. Immunol., 2021, 12, 716469.
[http://dx.doi.org/10.3389/fimmu.2021.716469] [PMID: 34434197]

Sun, S.C. The non-canonical NF-κB pathway in immunity and inflammation. Nat. Rev. Immunol., 2017, 17(9), 545-558.
[http://dx.doi.org/10.1038/nri.2017.52] [PMID: 28580957]

Patel, Y.; Heyward, C.A.; White, M.R.H.; Kell, D.B. Predicting the points of interaction of small molecules in the NF-κB pathway. BMC Syst. Biol., 2011, 5(1), 32.
[http://dx.doi.org/10.1186/1752-0509-5-32] [PMID: 21342508]

Munshi, A.; Ramesh, R. Mitogen-activated protein kinases and their role in radiation response. Genes Cancer, 2013, 4(9-10), 401-408.
[http://dx.doi.org/10.1177/1947601913485414] [PMID: 24349638]

Dent, P.; Yacoub, A.; Fisher, P.B.; Hagan, M.P.; Grant, S. MAPK pathways in radiation responses. Oncogene, 2003, 22(37), 5885-5896.
[http://dx.doi.org/10.1038/sj.onc.1206701] [PMID: 12947395]

Morrison, D.K. MAP kinase pathways. Cold Spring Harb. Perspect. Biol., 2012, 4(11), a011254.
[http://dx.doi.org/10.1101/cshperspect.a011254] [PMID: 23125017]

Harrison, D.A. The JAK/STAT Pathway. Cold Spring Harb. Perspect. Biol., 2012, 4(3), a011205.
[http://dx.doi.org/10.1101/cshperspect.a011205] [PMID: 22383755]

Seif, F.; Khoshmirsafa, M.; Aazami, H.; Mohsenzadegan, M.; Sedighi, G.; Bahar, M. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun. Signal., 2017, 15(1), 23.
[http://dx.doi.org/10.1186/s12964-017-0177-y] [PMID: 28637459]

Xin, P.; Xu, X.; Deng, C.; Liu, S.; Wang, Y.; Zhou, X.; Ma, H.; Wei, D.; Sun, S. The role of JAK/STAT signaling pathway and its inhibitors in diseases. Int. Immunopharmacol., 2020, 80, 106210.
[http://dx.doi.org/10.1016/j.intimp.2020.106210] [PMID: 31972425]

Hin Tang, J.J.; Hao Thng, D.K.; Lim, J.J.; Toh, T.B. JAK/STAT signaling in hepatocellular carcinoma. Hepat. Oncol., 2020, 7(1), HEP18.
[http://dx.doi.org/10.2217/hep-2020-0001] [PMID: 32273976]

Deorukhkar, A.; Krishnan, S. Targeting inflammatory pathways for tumor radiosensitization. Biochem. Pharmacol., 2010, 80(12), 1904-1914.
[http://dx.doi.org/10.1016/j.bcp.2010.06.039] [PMID: 20599771]

Bharadwaj, U.; Kasembeli, M.M.; Robinson, P.; Tweardy, D.J. Targeting Janus kinases and signal transducer and activator of transcription 3 to treat inflammation, fibrosis, and cancer: Rationale, progress, and caution. Pharmacol. Rev., 2020, 72(2), 486-526.
[http://dx.doi.org/10.1124/pr.119.018440] [PMID: 32198236]

Hein, A.L.; Ouellette, M.M.; Yan, Y. Radiation-induced signaling pathways that promote cancer cell survival (Review). Int. J. Oncol., 2014, 45(5), 1813-1819.
[http://dx.doi.org/10.3892/ijo.2014.2614] [PMID: 25174607]

Xu, F.; Na, L.; Li, Y.; Chen, L. RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci., 2020, 10(1), 54.
[http://dx.doi.org/10.1186/s13578-020-00416-0] [PMID: 32266056]

Padmanabhan, R.; Meskin, N.; Al Moustafa, A.E. Mathematical Models of Cancer and Different Therapies; Springer, 2021, pp. 123-133.
[http://dx.doi.org/10.1007/978-981-15-8640-8_6]

Rosenblatt, E.; Zubizarreta, E. Radiotherapy in cancer care: Facing the global challenge. Int. Atom. Energy Agency Vienna, 2017.

Baskar, R.; Dai, J.; Wenlong, N.; Yeo, R.; Yeoh, K.W. Biological response of cancer cells to radiation treatment. Front. Mol. Biosci., 2014, 1, 24.
[http://dx.doi.org/10.3389/fmolb.2014.00024] [PMID: 25988165]

Hubenak, J.R.; Zhang, Q.; Branch, C.D.; Kronowitz, S.J. Mechanisms of injury to normal tissue after radiotherapy: a review. Plast. Reconstr. Surg., 2014, 133(1), 49e-56e.
[http://dx.doi.org/10.1097/01.prs.0000440818.23647.0b] [PMID: 24374687]

Formenti, S.C.; Demaria, S. Systemic effects of local radiotherapy. Lancet Oncol., 2009, 10(7), 718-726.
[http://dx.doi.org/10.1016/S1470-2045(09)70082-8] [PMID: 19573801]

Ahmad, S.S.; Duke, S.; Jena, R.; Williams, M.V.; Burnet, N.G. Advances in radiotherapy. BMJ, 2012, 345(dec04 1), e7765.
[http://dx.doi.org/10.1136/bmj.e7765] [PMID: 23212681]

Khan, H.A.; Alhomida, A.S. A review of the logistic role of l-carnitine in the management of radiation toxicity and radiotherapy side effects. J. Appl. Toxicol., 2011, 31(8), 707-713.
[http://dx.doi.org/10.1002/jat.1716] [PMID: 21818761]

Chen, H.H.W.; Kuo, M.T. Improving radiotherapy in cancer treatment: Promises and challenges. Oncotarget, 2017, 8(37), 62742-62758.
[http://dx.doi.org/10.18632/oncotarget.18409] [PMID: 28977985]

Braunstein, S.; Nakamura, J.L. Radiotherapy-induced malignancies: Review of clinical features, pathobiology, and evolving approaches for mitigating risk. Front. Oncol., 2013, 3, 73.
[http://dx.doi.org/10.3389/fonc.2013.00073] [PMID: 23565507]

Vilalta, M.; Rafat, M.; Graves, E.E. Effects of radiation on metastasis and tumor cell migration. Cell. Mol. Life Sci., 2016, 73(16), 2999-3007.
[http://dx.doi.org/10.1007/s00018-016-2210-5] [PMID: 27022944]

Barker, H.E.; Paget, J.T.E.; Khan, A.A.; Harrington, K.J. The tumour microenvironment after radiotherapy: Mechanisms of resistance and recurrence. Nat. Rev. Cancer, 2015, 15(7), 409-425.
[http://dx.doi.org/10.1038/nrc3958] [PMID: 26105538]

Wang, J.; Wang, H.; Qian, H. Biological effects of radiation on cancer cells. Mil. Med. Res., 2018, 5(1), 20.
[http://dx.doi.org/10.1186/s40779-018-0167-4] [PMID: 29958545]

Majeed, H.; Gupta, V. Adverse effects of radiation therapy. StatPearls, 2020.

Gieringer, M.; Gosepath, J.; Naim, R. Radiotherapy and wound healing: Principles, management and prospects (Review). Oncol. Rep., 2011, 26(2), 299-307.
[http://dx.doi.org/10.3892/or.2011.1319] [PMID: 21617873]

Tang, L.; Wei, F.; Wu, Y.; He, Y.; Shi, L.; Xiong, F.; Gong, Z.; Guo, C.; Li, X.; Deng, H.; Cao, K.; Zhou, M.; Xiang, B.; Li, X.; Li, Y.; Li, G.; Xiong, W.; Zeng, Z. Role of metabolism in cancer cell radioresistance and radiosensitization methods. J. Exp. Clin. Cancer Res., 2018, 37(1), 87.
[http://dx.doi.org/10.1186/s13046-018-0758-7] [PMID: 29688867]

Galeaz, C.; Totis, C.; Bisio, A. Radiation resistance: A matter of transcription factors. Front. Oncol., 2021, 11, 662840.
[http://dx.doi.org/10.3389/fonc.2021.662840] [PMID: 34141616]

Mittal, M.; Siddiqui, M.R.; Tran, K.; Reddy, S.P.; Malik, A.B. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal., 2014, 20(7), 1126-1167.
[http://dx.doi.org/10.1089/ars.2012.5149] [PMID: 23991888]

Reuter, S.; Gupta, S.C.; Chaturvedi, M.M.; Aggarwal, B.B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic. Biol. Med., 2010, 49(11), 1603-1616.
[http://dx.doi.org/10.1016/j.freeradbiomed.2010.09.006] [PMID: 20840865]

Cheki, M.; Yahyapour, R.; Farhood, B.; Rezaeyan, A.; Shabeeb, D.; Amini, P.; Rezapoor, S.; Najafi, M. COX-2 in radiotherapy: A potential target for radioprotection and radiosensitization. Curr. Mol. Pharmacol., 2018, 11(3), 173-183.
[http://dx.doi.org/10.2174/1874467211666180219102520] [PMID: 29468988]

Lee, T.K.; Stupans, I. Radioprotection: The non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins. J. Pharm. Pharmacol., 2010, 54(11), 1435-1445.
[http://dx.doi.org/10.1211/00223570254] [PMID: 12495545]

Khayyal, M.T.; El-Ghazaly, M.A.; El-Hazek, R.M.; Nada, A.S. The effects of celecoxib, a COX-2 selective inhibitor, on acute inflammation induced in irradiated rats. Inflammopharmacology, 2009, 17(5), 255-266.
[http://dx.doi.org/10.1007/s10787-009-0014-z] [PMID: 19798548]

Demirel, C.; Kilciksiz, S.C.; Gurgul, S.; Erdal, N.; Yigit, S.; Tamer, L.; Ayaz, L. Inhibition of radiation-induced oxidative damage in the lung tissue: May acetylsalicylic acid have a positive role? Inflammation, 2016, 39(1), 158-165.
[http://dx.doi.org/10.1007/s10753-015-0234-x] [PMID: 26276129]

Hosseinimehr, S.J.; Nobakht, R.; Ghasemi, A.; Pourfallah, T.A. Radioprotective effect of mefenamic acid against radiation-induced genotoxicity in human lymphocytes. Radiat. Oncol. J., 2015, 33(3), 256-260.
[http://dx.doi.org/10.3857/roj.2015.33.3.256] [PMID: 26484310]

Alok, A.; Adhikari, J.S.; Chaudhury, N.K. Radioprotective role of clinical drug diclofenac sodium. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 2013, 755(2), 156-162.
[http://dx.doi.org/10.1016/j.mrgentox.2013.06.015] [PMID: 23827778]

Yamasaki, M.C.; Nejaim, Y.; Roque-Torres, G.D.; Freitas, D.Q. Meloxicam as a radiation-protective agent on mandibles of irradiated rats. Braz. Dent. J., 2017, 28(2), 249-255.
[http://dx.doi.org/10.1590/0103-6440201701271] [PMID: 28492757]

Dokmeci, D.; Akpolat, M.; Aydogdu, N.; Uzal, C.; Turan, N.F. The modifying effect of ibuprofen on total body irradiation-induced elevation of oxidative reactions in male hamsters. Acta Med. Biol., 2004, 52(2), 67-72.

Nishiguchi, I.; Furuta, Y.; Hunter, N.; Murray, D.; Milas, L. Radioprotection of hematopoietic tissues in mice by indomethacin. Radiat. Res., 1990, 122(2), 188-192.
[http://dx.doi.org/10.2307/3577605] [PMID: 2159648]

Hofmann, B.; Steinhilber, D. 5-Lipoxygenase inhibitors: A review of recent patents (2010 – 2012). Expert Opin. Ther. Pat., 2013, 23(7), 895-909.
[http://dx.doi.org/10.1517/13543776.2013.791678] [PMID: 23600432]

Peixoto, C.A.; Silva, B.S. Anti-inflammatory effects of diethylcarbamazine: A review. Eur. J. Pharmacol., 2014, 734, 35-41.
[http://dx.doi.org/10.1016/j.ejphar.2014.03.046] [PMID: 24726556]

Farzipour, S.; Amiri, F.T.; Mihandoust, E.; Shaki, F.; Noaparast, Z.; Ghasemi, A.; Hosseinimehr, S.J. Radioprotective effect of diethylcarbamazine on radiation-induced acute lung injury and oxidative stress in mice. J. Bioenerg. Biomembr., 2020, 52(1), 39-46.
[http://dx.doi.org/10.1007/s10863-019-09820-9] [PMID: 31853753]

Torabizadeh, S.A.; Rezaeifar, M.; Jomehzadeh, A.; Nabizadeh Haghighi, F.; Ansari, M. Radioprotective potential of sulindac sulfide to prevent DNA damage due to ionizing radiation. Drug Des. Devel. Ther., 2019, 13, 4127-4134.
[http://dx.doi.org/10.2147/DDDT.S218022] [PMID: 31827319]

Hosseinimehr, S.; Fathi, M.; Ghasemi, A.; Shiadeh, S.R.; Pourfallah, T. Celecoxib mitigates genotoxicity induced by ionizing radiation in human blood lymphocytes. Res. Pharm. Sci., 2017, 12(1), 82-87.
[http://dx.doi.org/10.4103/1735-5362.199051] [PMID: 28255318]

Hormati, A.; Ahmadpour, S.; Afkhami Ardekani, M.; Khodadust, F.; Refahi, S. Radioprotective effects of montelukast, a selective leukotriene CysLT1 receptor antagonist, against nephrotoxicity induced by gamma radiation in mice. J. Biochem. Mol. Toxicol., 2020, 34(6), e22479.
[http://dx.doi.org/10.1002/jbt.22479] [PMID: 32125029]

Tokat, A.O.; Akbulut, A.; Billur, D.; Koca, G.; Bayram, P.; Kuru, S.; Karasu, S.; Aydogmus, S.; Cakmak, H.; Ozmert, S.; Korkmaz, M. Montelukast attenuates radioactive I131-induced pulmonary damage on rats. Int. J. Radiat. Biol., 2018, 94(6), 542-550.
[http://dx.doi.org/10.1080/09553002.2018.1466065] [PMID: 29659324]

Koca, G.; Gültekin, S.S.; Han, Ü.; Kuru, S.; Demirel, K.; Korkmaz, M. The efficacy of montelukast as a protective agent against 131I-induced salivary gland damage in rats. Nucl. Med. Commun., 2013, 34(5), 507-517.
[http://dx.doi.org/10.1097/MNM.0b013e32835ffecd] [PMID: 23478587]

Di Raimondo, D.; Tuttolomondo, A.; Buttà, C.; Miceli, S.; Licata, G.; Pinto, A. Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation. Curr. Pharm. Des., 2012, 18(28), 4385-4413.
[http://dx.doi.org/10.2174/138161212802481282] [PMID: 22283779]

Robbins, M.E.; Diz, D.I. Pathogenic role of the renin–angiotensin system in modulating radiation-induced late effects. Int. J. Radiat. Oncol. Biol. Phys., 2006, 64(1), 6-12.
[http://dx.doi.org/10.1016/j.ijrobp.2005.08.033] [PMID: 16377409]

Hitomi, H.; Kiyomoto, H.; Nishiyama, A. Angiotensin II and oxidative stress. Curr. Opin. Cardiol., 2007, 22(4), 311-315.
[http://dx.doi.org/10.1097/HCO.0b013e3281532b53] [PMID: 17556883]

Benzie, I.F.F.; Tomlinson, B. Antioxidant power of angiotensin-converting enzyme inhibitors in vitro. Br. J. Clin. Pharmacol., 1998, 45(2), 168-169.
[http://dx.doi.org/10.1046/j.1365-2125.1998.00664.x] [PMID: 9491832]

Bhuyan, B.J.; Mugesh, G. Synthesis, characterization and antioxidant activity of angiotensin converting enzyme inhibitors. Org. Biomol. Chem., 2011, 9(5), 1356-1365.
[http://dx.doi.org/10.1039/C0OB00823K] [PMID: 21186397]

Hosseinimehr, S.J.; Mahmoudzadeh, A.; Akhlagpour, S. Captopril protects mice bone marrow cells against genotoxicity induced by gamma irradiation. Cell Biochem. Funct., 2007, 25(4), 389-394.
[http://dx.doi.org/10.1002/cbf.1311] [PMID: 16447141]

Davis, T.A.; Landauer, M.R.; Mog, S.R.; Barshishat-Kupper, M.; Zins, S.R.; Amare, M.F.; Day, R.M. Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation. Exp. Hematol., 2010, 38(4), 270-281.
[http://dx.doi.org/10.1016/j.exphem.2010.01.004] [PMID: 20116413]

Rittase, W.B.; McCart, E.A.; Muir, J.M.; Bouten, R.M.; Slaven, J.E.; Mungunsukh, O.; Bylicky, M.A.; Wilkins, W.L.; Lee, S.H.; Gudmundsson, K.O.; Di Pucchio, T.; Olsen, C.H.; Du, Y.; Day, R.M. Effects of captopril against radiation injuries in the Göttingen minipig model of hematopoietic-acute radiation syndrome. PLoS One, 2021, 16(8), e0256208.
[http://dx.doi.org/10.1371/journal.pone.0256208] [PMID: 34449797]

Yoon, S.-C.; Park, J.-M.; Jang, H.-S.; Shinn, K.-S.; Bahk, Y.-W. Radioprotective effect of captopril on the mouse jejunal mucosa. Int. J. Radiat. Oncol. Biol. Phys., 1994, 30(4), 873-878.
[http://dx.doi.org/10.1016/0360-3016(94)90363-8] [PMID: 7960990]

Day, R.M.; Davis, T.A.; Barshishat-Kupper, M.; McCart, E.A.; Tipton, A.J.; Landauer, M.R. Enhanced hematopoietic protection from radiation by the combination of genistein and captopril. Int. Immunopharmacol., 2013, 15(2), 348-356.
[http://dx.doi.org/10.1016/j.intimp.2012.12.029] [PMID: 23328620]

Charrier, S.; Michaud, A.; Badaoui, S.; Giroux, S.; Ezan, E.; Sainteny, F.; Corvol, P.; Vainchenker, W. Inhibition of angiotensin I–converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells. Blood, 2004, 104(4), 978-985.
[http://dx.doi.org/10.1182/blood-2003-11-3828] [PMID: 15105290]

Fooladi, M.; Cheki, M.; Shirazi, A.; Sheikhzadeh, P.; Amirrashedi, M.; Ghahramani, F.; Khoobi, M. Histopathological evaluation of protective effect of telmisartan against radiation-induced bone marrow injury. J. Biomed. Phys. Eng., 2021, 12(3), 277-284.
[PMID: 35698535]

Markowitz, J.F. Pediatric Gastrointestinal and Liver Disease W.B. Saunders: Saint Louis, 2011; pp. 490-504..

Pearson, D.C.; Jourd’Heuil, D.; Meddings, J.B. The anti-oxidant properties of 5-aminosalicylic acid. Free Radic. Biol. Med., 1996, 21(3), 367-373.
[http://dx.doi.org/10.1016/0891-5849(96)00031-7] [PMID: 8855448]

Koelink, P.J. 5-ASA-colorectal cancer-cell death: an intriguing threesome; Leiden University, 2010.

Mantena, S.K.; Unnikrishnan, M.K.; Joshi, R.; Radha, V.; Devi, P.U.; Mukherjee, T. In vivo radioprotection by 5-aminosalicylic acid. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 2008, 650(1), 63-79.
[http://dx.doi.org/10.1016/j.mrgentox.2007.10.005] [PMID: 18155638]

Sudheer Kumar, M.; Unnikrishnan, M.K.; Uma Devi, P. Effect of 5-aminosalicylic acid on radiation-induced micronuclei in mouse bone marrow. Mutat. Res., 2003, 527(1-2), 7-14.
[http://dx.doi.org/10.1016/S0027-5107(03)00052-6] [PMID: 12787909]

Hall, S.; Rudrawar, S.; Zunk, M.; Bernaitis, N.; Arora, D.; McDermott, C.; Anoopkumar-Dukie, S. Protection against radiotherapy-induced toxicity. Antioxidants, 2016, 5(3), 22.
[http://dx.doi.org/10.3390/antiox5030022] [PMID: 27399787]

Dutta, S.; Wadekar, R.R.; Roy, T. Radioprotective natural products as alternative complements in oncological radiotherapy. Bol. Latinoam. Caribe Plantas Med. Aromat., 2021, 20(2), 101-122.
[http://dx.doi.org/10.37360/blacpma.21.20.2.9]

Mantena, S.K.; Unnikrishnan, M.K.; Uma Devi, P. Radioprotective effect of sulfasalazine on mouse bone marrow chromosomes. Mutagenesis, 2008, 23(4), 285-292.
[http://dx.doi.org/10.1093/mutage/gen005] [PMID: 18353769]

Kim, S.W.; Kang, H.J.; Jhon, M.; Kim, J.W.; Lee, J.Y.; Walker, A.J.; Agustini, B.; Kim, J.M.; Berk, M. Statins and inflammation: New therapeutic opportunities in psychiatry. Front. Psychiatry, 2019, 10, 103.
[http://dx.doi.org/10.3389/fpsyt.2019.00103] [PMID: 30890971]

Bedi, O.; Dhawan, V.; Sharma, P.L.; Kumar, P. Pleiotropic effects of statins: New therapeutic targets in drug design. Naunyn Schmiedebergs Arch. Pharmacol., 2016, 389(7), 695-712.
[http://dx.doi.org/10.1007/s00210-016-1252-4] [PMID: 27146293]

Davignon, J.; Jacob, R.F.; Mason, R.P. The antioxidant effects of statins. Coron. Artery Dis., 2004, 15(5), 251-258.
[http://dx.doi.org/10.1097/01.mca.0000131573.31966.34] [PMID: 15238821]

Fritz, G.; Henninger, C.; Huelsenbeck, J. Potential use of HMG-CoA reductase inhibitors (statins) as radioprotective agents. Br. Med. Bull., 2011, 97(1), 17-26.
[http://dx.doi.org/10.1093/bmb/ldq044] [PMID: 21252099]

Talebpour Amiri, F.; Hamzeh, M.; Naeimi, R.A.; Ghasemi, A.; Hosseinimehr, S.J. Radioprotective effect of atorvastatin against ionizing radiation-induced nephrotoxicity in mice. Int. J. Radiat. Biol., 2018, 94(2), 106-113.
[http://dx.doi.org/10.1080/09553002.2018.1420926] [PMID: 29268056]

Hosseinimehr, S.J.; Izakmehri, M.; Ghasemi, A. In vitro protective effect of atorvastatin against ionizing radiation induced genotoxicity in human lymphocytes. Cell. Mol. Biol., 2015, 61(1), 68-71.
[PMID: 25817349]

Naeimi, R.A.; Talebpour Amiri, F.; Khalatbary, A.R.; Ghasemi, A.; Zargari, M.; Ghesemi, M.; Hosseinimehr, S.J. Atorvastatin mitigates testicular injuries induced by ionizing radiation in mice. Reprod. Toxicol., 2017, 72, 115-121.
[http://dx.doi.org/10.1016/j.reprotox.2017.06.052] [PMID: 28668617]

Doi, H.; Matsumoto, S.; Odawara, S.; Shikata, T.; Kitajima, K.; Tanooka, M.; Takada, Y.; Tsujimura, T.; Kamikonya, N.; Hirota, S. Pravastatin reduces radiation-induced damage in normal tissues. Exp. Ther. Med., 2017, 13(5), 1765-1772.
[http://dx.doi.org/10.3892/etm.2017.4192] [PMID: 28565765]

Yang, H.; Huang, F.; Tao, Y.; Zhao, X.; Liao, L.; Tao, X. Simvastatin ameliorates ionizing radiation-induced apoptosis in the thymus by activating the AKT/sirtuin 1 pathway in mice. Int. J. Mol. Med., 2017, 40(3), 762-770.
[http://dx.doi.org/10.3892/ijmm.2017.3047] [PMID: 28677744]

Sun, X.; Yang, X.; Chen, J.; Ge, X.L.; Qin, Q.; Zhu, H.; Zhang, C.; Xu, L. Simvastatin attenuates radiation-induced salivary gland dysfunction in mice. Drug Des. Devel. Ther., 2016, 10, 2271-2278.
[http://dx.doi.org/10.2147/DDDT.S105809] [PMID: 27471375]

Zhao, X.; Yang, H.; Jiang, G.; Ni, M.; Deng, Y.; Cai, J.; Li, Z.; Shen, F.; Tao, X. Simvastatin attenuates radiation-induced tissue damage in mice. J. Radiat. Res., 2014, 55(2), 257-264.
[http://dx.doi.org/10.1093/jrr/rrt115] [PMID: 24105712]

Ziegler, V.; Henninger, C.; Simiantonakis, I.; Buchholzer, M.; Ahmadian, M.R.; Budach, W.; Fritz, G. Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation. Cell Death Dis., 2017, 8(8), e2978-e2978.
[http://dx.doi.org/10.1038/cddis.2017.372] [PMID: 28796249]

El-Batal, A.I.; Thabet, N.M.; Osman, A.; Ghaffar, A.; Azab, K.S. Amelioration of oxidative damage induced in gamma irradiated rats by nano selenium and lovastatin mixture. World Appl. Sci. J., 2012, 19(7), 962-971.

Nübel, T.; Damrot, J.; Roos, W.P.; Kaina, B.; Fritz, G. Lovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaks. Clin. Cancer Res., 2006, 12(3), 933-939.
[http://dx.doi.org/10.1158/1078-0432.CCR-05-1903] [PMID: 16467108]

Xourgia, E.; Tzouganatou, E.M.; Papazafiropoulou, A.; Melidonis, A. Anti-inflammatory properties of antidiabetic agents. World J. Metaanal., 2019, 7(4), 129-141.
[http://dx.doi.org/10.13105/wjma.v7.i4.129]

Hasanpour Dehkordi, A.; Abbaszadeh, A.; Mir, S.; Hasanvand, A. Metformin and its anti-inflammatory and anti-oxidative effects; new concepts. J. Renal Inj. Prev., 2019, 8(1), 54-61.
[http://dx.doi.org/10.15171/jrip.2019.11]

Da, F.; Guo, J.; Yao, L.; Gao, Q.; Jiao, S.; Miao, X.; Liu, J. Pretreatment with metformin protects mice from whole-body irradiation. J. Radiat. Res., 2021, 62(4), 618-625.
[http://dx.doi.org/10.1093/jrr/rrab012] [PMID: 33912960]

Mortezaee, K.; Shabeeb, D.; Musa, A.E.; Najafi, M.; Farhood, B. Metformin as a radiation modifier; implications to normal tissue protection and tumor sensitization. Curr. Clin. Pharmacol., 2019, 14(1), 41-53.
[http://dx.doi.org/10.2174/1574884713666181025141559] [PMID: 30360725]

Cheki, M.; Shirazi, A.; Mahmoudzadeh, A.; Bazzaz, J.T.; Hosseinimehr, S.J. The radioprotective effect of metformin against cytotoxicity and genotoxicity induced by ionizing radiation in cultured human blood lymphocytes. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 2016, 809, 24-32.
[http://dx.doi.org/10.1016/j.mrgentox.2016.09.001] [PMID: 27692296]

Liu, H.; Wang, S.; Wu, Z.; Huang, Z.; Chen, W.; Yang, Y.; Cui, J.; Liu, C.; Zhao, H.; Guo, J.; Zhang, P.; Gao, F.; Li, B.; Cai, J. Glibenclamide, a diabetic drug, prevents acute radiation-induced liver injury of mice via up-regulating intracellular ROS and subsequently activating Akt-NF-κB pathway. Oncotarget, 2017, 8(25), 40568-40582.
[http://dx.doi.org/10.18632/oncotarget.16501] [PMID: 28380448]

Pouri, M.; Shaghaghi, Z.; Ghasemi, A.; Hosseinimehr, S.J. Radioprotective effect of gliclazide as an anti-hyperglycemic agent against genotoxicity induced by ionizing radiation on human lymphocytes. Cardiovasc. Hematol. Agents Med. Chem., 2019, 17(1), 40-46.
[http://dx.doi.org/10.2174/1871525717666190524092918] [PMID: 31124426]

Heliövaara, M.K.; Herz, M.; Teppo, A.M.; Leinonen, E.; Ebeling, P. Pioglitazone has anti-inflammatory effects in patients with Type 2 diabetes. J. Endocrinol. Invest., 2007, 30(4), 292-297.
[http://dx.doi.org/10.1007/BF03346296] [PMID: 17556865]

Kazemi, R.; Hosseinimehr, S.J. Radioprotective effect of pioglitazone against genotoxicity induced by ionizing radiation in healthy human lymphocytes. Cardiovasc. Hematol. Agents Med. Chem., 2021, 19(1), 72-75.
[http://dx.doi.org/10.2174/1871525718666200525005231] [PMID: 32448107]

Kuruba, V.; Gollapalli, P. Natural radioprotectors and their impact on cancer drug discovery. Radiat. Oncol. J., 2018, 36(4), 265-275.
[http://dx.doi.org/10.3857/roj.2018.00381] [PMID: 30630265]

Hussain, T.; Tan, B.; Yin, Y.; Blachier, F.; Tossou, M.C.; Rahu, N. Oxidative stress and inflammation: What polyphenols can do for us? Oxid. Med. Cell Longev., 2016, 2016, 7432797.
[http://dx.doi.org/10.1155/2016/7432797]

Adnan, M.; Rasul, A.; Shah, M.A.; Hussain, G.; Asrar, M.; Riaz, A.; Sarfraz, I.; Hussain, A.; Khorsandi, K.; Lai, N.S. Radioprotective role of natural polyphenols: From sources to mechanisms. Anticancer Agents Med. Chem., 2022, 22(1), 30-39.
[http://dx.doi.org/10.2174/1871520621666210419095829] [PMID: 33874875]

Faramarzi, S.; Piccolella, S.; Manti, L.; Pacifico, S. Could polyphenols really be a good radioprotective strategy? Molecules, 2021, 26(16), 4969.
[http://dx.doi.org/10.3390/molecules26164969] [PMID: 34443561]

Kumar, S.; Pandey, A.K. Chemistry and biological activities of flavonoids: An overview. ScientificWorldJournal, 2013, 2013, 162750.
[http://dx.doi.org/10.1155/2013/162750]

Procházková, D.; Boušová, I.; Wilhelmová, N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia, 2011, 82(4), 513-523.
[http://dx.doi.org/10.1016/j.fitote.2011.01.018] [PMID: 21277359]

Heim, K.E.; Tagliaferro, A.R.; Bobilya, D.J. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem., 2002, 13(10), 572-584.
[http://dx.doi.org/10.1016/S0955-2863(02)00208-5] [PMID: 12550068]

Pietta, P.G. Flavonoids as antioxidants. J. Nat. Prod., 2000, 63(7), 1035-1042.
[http://dx.doi.org/10.1021/np9904509] [PMID: 10924197]

Maleki, S.J.; Crespo, J.F.; Cabanillas, B. Anti-inflammatory effects of flavonoids. Food Chem., 2019, 299, 125124.
[http://dx.doi.org/10.1016/j.foodchem.2019.125124] [PMID: 31288163]

Choy, K.W.; Murugan, D.; Leong, X.F.; Abas, R.; Alias, A.; Mustafa, M.R. Flavonoids as natural anti-inflammatory agents targeting nuclear factor-kappa B (NFκB) signaling in cardiovascular diseases: A mini review. Front. Pharmacol., 2019, 10, 1295.
[http://dx.doi.org/10.3389/fphar.2019.01295] [PMID: 31749703]

Serafini, M.; Peluso, I.; Raguzzini, A. Flavonoids as anti-inflammatory agents. Proc. Nutr. Soc., 2010, 69(3), 273-278.
[http://dx.doi.org/10.1017/S002966511000162X] [PMID: 20569521]

Wang, Q.; Xie, C.; Xi, S.; Qian, F.; Peng, X.; Huang, J.; Tang, F. Radioprotective effect of flavonoids on ionizing radiation-induced brain damage. Molecules, 2020, 25(23), 5719.
[http://dx.doi.org/10.3390/molecules25235719] [PMID: 33287417]

Mashhadi, A.B.M. An overview of the cellular mechanisms of flavonoids radioprotective effects. Adv. Pharm. Bull., 2019, 10(1), 13-19.
[http://dx.doi.org/10.15171/apb.2020.002] [PMID: 32002357]

Hosseinimehr, S.J.; Ahmadi, A.; Beiki, D.; Habibi, E.; Mahmoudzadeh, A. Protective effects of hesperidin against genotoxicity induced by 99mTc-MIBI in human cultured lymphocyte cells. Nucl. Med. Biol., 2009, 36(7), 863-867.
[http://dx.doi.org/10.1016/j.nucmedbio.2009.06.002] [PMID: 19720298]

Hosseinimehr, S.J.; Mahmoudzadeh, A.; Ahmadi, A.; Mohamadifar, S.; Akhlaghpoor, S. Radioprotective effects of hesperidin against genotoxicity induced by -irradiation in human lymphocytes. Mutagenesis, 2009, 24(3), 233-235.
[http://dx.doi.org/10.1093/mutage/gep001] [PMID: 19193695]

El-Gazzar, M.G.; Zaher, N.H.; El-Hossary, E.M.; Ismail, A.F.M. Radio-protective effect of some new curcumin analogues. J. Photochem. Photobiol. B, 2016, 162, 694-702.
[http://dx.doi.org/10.1016/j.jphotobiol.2016.08.002] [PMID: 27505300]

Tang, F.R.; Loke, W.K.; Wong, P.; Khoo, B.C. Radioprotective effect of ursolic acid in radiation-induced impairment of neurogenesis, learning and memory in adolescent BALB/c mouse. Physiol. Behav., 2017, 175, 37-46.
[http://dx.doi.org/10.1016/j.physbeh.2017.03.027] [PMID: 28341234]

Wang, H.; Sim, M.K.; Loke, W.K.; Chinnathambi, A.; Alharbi, S.A.; Tang, F.R.; Sethi, G. Potential protective effects of ursolic acid against gamma irradiation-induced damage are mediated through the modulation of diverse inflammatory mediators. Front. Pharmacol., 2017, 8, 352.
[http://dx.doi.org/10.3389/fphar.2017.00352] [PMID: 28670276]

Asadullina, N.; Gudkov, S.; Bruskov, V. Biochemistry and Biophysics. In: Springer Nature BV; , 2012; 442, p. 22.

Najafi, M.; Shirazi, A.; Motevaseli, E.; Rezaeyan, A.H.; Salajegheh, A.; Rezapoor, S. Melatonin as an anti-inflammatory agent in radiotherapy. Inflammopharmacology, 2017, 25(4), 403-413.
[http://dx.doi.org/10.1007/s10787-017-0332-5] [PMID: 28255737]

AlMathkour, M.M.; AlSuhaibani, E.S. Protective effect of aspirin on γ radiation-induced sperm malformations in Swiss Albino male mice. Am. J. Life Sci., 2014, 2(4), 205-215.
[http://dx.doi.org/10.11648/j.ajls.20140204.13]

Koca, G.; Yalniz-Akkaya, Z.; Gültekin, S.S.; Yumusak, N.; Demirel, K.; Korkmaz, M.; Atilgan, H.I.; Altiparmak, U.E.; Onal, B.; Ornek, F. Radioprotective effect of montelukast sodium in rat lacrimal glands after radioiodine treatment. Rev. Esp. Med. Nucl. Imagen Mol., 2013, 32(5), 294-300.
[PMID: 23499122]

Atilgan, H.I.; Yumuşak, N.; Sadic, M.; Gultekin, S.S.; Gokhan, K.; Ozyurt, S.; Demirel, K.; Korkmaz, M. Radioprotective effect of montelukast sodium against hepatic radioiodine (131I) toxicity: A histopathological investigation in the rat model. Ankara Univ. Vet. Fak. Derg., 2015, 62(1), 37-43.
[http://dx.doi.org/10.1501/Vetfak_0000002655]

Ostrau, C.; Hülsenbeck, J.; Herzog, M.; Schad, A.; Torzewski, M.; Lackner, K.J.; Fritz, G. Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo. Radiother. Oncol., 2009, 92(3), 492-499.
[http://dx.doi.org/10.1016/j.radonc.2009.06.020] [PMID: 19615773]